TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CCCC

C4 Therapeutics Inc

Healthcare · Biotechnology

3.10$ -6.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow CCCC
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – -220.9% – – – – –
– +25.3% +1.4% -7.7% +12.3% +12.2% -3.3% +7.8%
– +182.1% +109.0% +526.8% +39.5% -9.3% +8.9% -35.6%
– +178.2% +413.9% +110.1% +39.5% – – –
– – -115.5% – – – – -482.9%
– -49.8% -51.8% +96.5% +330.4% -68.9% -89.5% +237.2%
– -104.4% +11,659.6% -0.6% – +171.0% -132.4% -83.2%
– – – – – – – –
– -52.4% +546.7% – -62.0% -114.2% +76.4% -0.5%
– +0.0% +0.0% -100.0% – – -100.0% –
– -87.6% +142,904.9% -50.9% -99.3% +3,865.9% -0.3% +178.8%
– +147.7% +68.1% -215.1% – – -173.3% –
– – -225.1% – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?